Key result
Aortic valve replacement yields disease-free survival at 4-year follow-up in rare fibroelastoma AA amyloidosis.
Case Report (n=1)
This case highlights an exceptionally rare presentation of AA amyloidosis with cardiac involvement, diagnosed via amyloid A deposition within an aortic valve fibroelastoma following suggestive multimodal imaging.
Answers are grounded in this paper and cite their sources.
Case of AF stroke with low-voltage hypertrophy and AV masses suggests amyloidosis; hypothesis-generating, requires prospective validation before clinical adoption.
A 53-year-old woman with a history of cerebral infarction was admitted with new-onset left-sided weakness. Electrocardiography showed atrial fibrillation, low QRS voltage in limb leads (III, aVL, aVF ≤ 5 mm), and QRS fragmentation (III, aVF) (Panel A).1,2 Echocardiography revealed two aortic valve (AV) masses (1.1 × 0.9 cm and 0.6 × 0.6 cm) and concentric biventricular hypertrophy (Panel B). Ejection fraction was 65%, but reduced E′ (4.27 cm/s) and elevated E/E′ (31.8) indicated diastolic dysfunction. Speckle tracking echocardiography revealed an apical sparing pattern, with markedly reduced strain in basal segments and relative preservation towards the apex (Panel B). Cardiac magnetic resonance imaging (MRI) with late gadolinium enhancement (LGE) at 15 min demonstrated scattered lesions in both ventricles, showing focal and diffuse patchy LGE patterns, with involvement of subendocardial, subepicardial, and transmural enhancement (Panel C, left).3 Multi-slice short-axis LGE with region-of-interest analysis (Panel C, right) showed orange overlays indicating myocardial regions consistent with amyloid infiltration. Although these findings suggested cardiac amyloidosis, subsequent evaluations for AL and ATTR subtypes were negative. The patient underwent AV replacement which revealed AV masses with gelatinous material (see Supplementary data online, Figure S1). Histopathology confirmed papillary fibroelastoma with amyloid A deposition, characterized by arborizing fronds (Panel D, left) containing amorphous acellular eosinophilic material (Panel D, middle) that exhibited apple-green birefringence on Congo red staining (Panel D, right), establishing AA amyloidosis. At 4-year follow-up, the patient remains well without heart failure. Systemic amyloidosis with cardiac involvement typically arises from AL or ATTR subtypes, whereas AA amyloidosis rarely involves the heart.4,5 This case illustrates an exceptionally rare manifestation, in which AA amyloidosis with cardiac involvement was confirmed by amyloid A deposition within AV fibroelastoma, preceded by multimodal imaging findings strongly suggestive of cardiac amyloidosis. Supplementary data are available at European Heart Journal online. All authors declare no disclosures of interest for this contribution. All relevant data are contained within the article. Further information is available from the corresponding author upon reasonable request. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2025) conducted a case report in AA amyloidosis with cardiac involvement (n=1). Aortic valve replacement was evaluated. Aortic valve replacement in a 53-year-old woman with rare AA amyloidosis involving an aortic valve fibroelastoma resulted in her remaining well without heart failure at 4-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: